By Stan Aronow | July 29, 2022
The Messy Reality of Supply Chain Automation
June 05 2026
By Stan Aronow | July 29, 2022
In mid-July, we held our annual Supply Chain Leaders Forum event in London. It was a glorious in-person reunion for our community of COOs and heads of large global supply chains.

The theme of this year’s conference was “The Supply Chain New Deal.” Almost a century ago, in the depths of the Great Depression, there was a massive shift in the relationship between government and society. In the United States, this was called The New Deal, and we now use the phrase to indicate changing paradigms.
The unprecedented disruption of the past three years has driven similar seismic changes in our world of supply chain. We explored the positive and negative implications of these changes during our two days together at Leaders Forum. And those changes and their implications have led to the development of the Supply Chain New Deal.

One silver lining of this New Deal is that supply chain and operations leaders play a much more impactful role for their companies, and the ecosystems they influence for results and change. Despite an environment of unending risk and disruption, supply chain has emerged as a partner for growth in the business.
Our leaders have been steadily handed more scope including, in many cases, significant roles in product development, customer experience, sustainability and digital transformation. Boards and executive committees now recognize supply chain’s critical role in helping the business survive and thrive.
Of course, none of these results can be accomplished without our people. The leaders in our community share an intense focus on being competitive, collaborative and connected in the current age of hybrid work and on a journey toward hyper-automation.
We had a stellar line up of speakers at this year’s event, including an opening keynote by Joaquin Duato, CEO and board member at Johnson & Johnson (J&J). Duato gave an inspiring talk that highlighted the fact that advances in digital, coupled with developments in personalized therapies, are priming a medical revolution – one that may drive more progress in healthcare over the next 10 years than in the last century.
What really struck me about Duato’s talk was how critical supply chain will be in delivering this vision. He referred to supply chain as the connective tissue between R&D, commercial, customers and suppliers, which is becoming increasingly important as J&J shifts to delivering more patient-specific, gene-based therapies. Duato also expressed a high degree of respect for supply chain as a function and, more specifically, Kathy Wengel as its longtime leader at J&J. That feeling really comes through in the photo below of them waiting to join me on stage for a fireside chat session.

Here are some key takeaways from keynotes and group discussions at this year’s event:
On the rising influence and accountability of the supply chain organization and leader:
On driving growth in a risky environment:
On the intersection of talent and digital:
It was an inspiring two days together at Leaders Forum. We are excited to reconvene this esteemed group of leaders at our North American and European Leaders in Action events, scheduled for this autumn.
Stan Aronow
VP Distinguished Advisor
Gartner Supply Chain
Stan.Aronow@gartner.com
Listen and subscribe to the Gartner Supply Chain Podcast on Gartner.com, Apple Podcasts, Spotify and Google Podcasts
Beyond Supply Chain
Subscribe on LinkedIn to receive the biweekly Beyond Supply Chain newsletter.